Early outcomes after allogeneic hematopoietic SCT in pediatric patients with hematologic malignancies following single fraction TBI

Bone Marrow Transplantation

Volumn 43, Issue 4, 2009, Pages 307-314

  Druley, T E ^a   Hayashi, R ^a   Mansur, D B ^a   Zhang, Q ^a   Barnes, Y ^a   Trinkaus, K ^a   Witty, S ^a   Thomas, T ^a   Klein, E E ^a   DiPersio, J F ^a   Adkins, D ^a   Shenoy, S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BURKITT LYMPHOMA; CANCER RELAPSE; CHILD; CHILD CARE; ENGRAFTMENT; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMOLYTIC ANEMIA; HUMAN; INFECTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA INFLAMMATION; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SHOCK; SURVIVAL RATE; SURVIVAL TIME; VEIN OCCLUSION; WHOLE BODY RADIATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; NEUTROPHILS; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 61449097475     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.327     Document Type: Article

References (32)

1. Gale R, Butturini A, Bortin M. What does total body radiation do in bone marrow transplants for leukemia? Int J Radiat Oncol Biol Phys 1991; 20: 631-634.
2. Morgan M, Dodds A, Atkinson K, Szer J, Downs K, Bigg J. The toxicity of busulphan and cyclophosphamide as preparative regimen for bone marrow transplantation. Br J Haematol 1991; 77: 529-534.
3. Matthes-Martin S, Lamche M, Ladenstein R, Emminger W. Felsberger C, Topf R et al. Organ toxicity and quality of after allogeneic bone marrow transplantation in pediatric patients: A single centre retrospective analysis. Bone Marrow Transplant 1999; 23: 1049-1053.
4. Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M. et al. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant. Int J Radiat Oncol Biol Phys 2005; 63: 1568-1575.
5. Sims S, Kazak A, Golomb V, Goldwein J, Bunin N. Cognitive, behavioral and social outcome in survivors of childhood stem cell transplantation. J Pediatr Hematol Oncol 2002; 24: 115-119.
6. Schwartz J, Yeager A. Reduced-intensity allogeneic hematopoietic cell transplantation: Graft versus tumor effects with decreased toxicity. Pediatr Transplant 2003; 7: 168-178.
7. Roman E, Cooney E, Harrison L, Militano O, Wolownik K, Hawks R et al Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia. Clin Cancer Res 2005; 11: 7164s-7170s.
8. Davies S, Ramsay N, Klein J, Weisdorf D, Bolwell B, Cahn J et al. Comparison of preparative regimens in transplants children with acute lymphoblastic leukemia. J Clin Oncol 2000; 18: 340-347.
9. Bunin N, Aplenc R, Kamani N, Shaw K, Cnaan A, Simms S. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: A Pediatric Blood and Marrow Transplant Consortium study. Bone Marrow Transplant 2003; 32: 543-548.
10. Eapen M, Raetz E, Zhang M, Muehlenbein C, Devidas M, Abshire T et al Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in second remission: A collaborative study of the Children's Oncology Group and Center for International Bone Marrow Transplant Research. Blood 2006; 107: 4961-4967.
11. Storb R, Raff R, Appelbaum F, Deeg H, Graham T, Schuening F. Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts. Blood 1994; 83: 3384-3389.
12. Down J, Tarbell N, Thames H, Mauch P. Syngeneic and allogeneic bone marrow engraftment after total body irradiation: Dependence on dose, rate, and fractionation. Blood 1991; 77: 661-669.
13. Khoury H, Adkins D, Brown R, Pence H, Vij R, Goodnough L et al. Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with low-dose (550 cGy) total body irradiation conditioning regimen. Biol Blood Marrow Transplant 2001; 7: 352-358.
14. Blum W, Brown R, Lin H, Zehnbauer B, Khoury H, Goodnough L et al. Low dose (550 cGy), single exposure total body irradiation and cyclophosphamide: Consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity. Biol Blood Marrow Transplant 2002; 8: 608-618.
15. Hallemeier C, Girgis M, Blum W, Brown R, Khoury H, Goodnough L et al Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants. Biol Blood Marrow Transplant 2004; 10: 310-319.
16. Girgis M, Hallemeier C, Blum W, Brown R, Lin H, Khoury H et al. Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide. Blood 2005; 105: 3035-3041.
17. Blood Marrow Transplant Clinical Trials Network, Technical Manual of Procedures, Version 2.0. National Institutes of Health; National Heart Lung Blood Institute; National Cancer Institute, Rockville, MD, USA, 2005.
18. Przepiorka D, Weisdorf D, Martin P, Klingemann H, Beatty P, Hows J, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
19. Rankin K, Jones D, Redding S. Oral Health in Cancer Therapy: A Guide for Health Care Professionals, 2nd edn. Texas Cancer Council: Dallas, 2003.
20. Hartsell W, Czyzewski E, Ghalie R, Kaizer H. Pulmonary complications of bone marrow transplantation: A comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide. Int J Radiat Oncol Biol Phys 1995; 32: 69-73.
21. Ozsahin M, Belkacemi Y, Pene F, Laporte J, Rio B, Leblond V et al. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation. Int J Radiat Oncol Biol Phys 1996; 34: 71-77.
22. Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: Part II - CIBMTR Summary Slides 2007 CIBMTR Newsletter (serial online) 2008; 14: 6-13.
23. Gibson B, Wheatley K, Hann I, Stevens R, Webb D, Hills R et al. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia 2005; 19: 2130-2138.
24. Lazarus H, Perez W, LKlein J, Kollman C, Bate-Boyle B, Bredenson C et al. Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukemia: A retrospective analysis from the Center for International Bone Marrow Transplant Research. Br J Haematol 2006; 132: 755-769.
25. Ravindranath Y, Chang M, Steuber C, Becton D, Dahl G, Civin C et al Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): A review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 2005; 19: 2101-2116.
26. Meisel R, Laws H, Balzer S, Bernbeck B, Kramm C, Schonberger S et al Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies. Biol Blood Marrow Transplant 2007; 13: 1338-1345.
27. Malempati S, Gaynon P, Sather H, La M, Stork L, Children's Oncology Group. Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group Study CCG-1952. J Clin Oncol 2007; 25: 5800-5807.
28. Gassas A, Sung L, Saunders E, Doyle J. Graft-versus-leukaemia effect in hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukaemia: Significantly lower relapse rate in unrelated transplantations. Bone Marrow Transplant 2007; 40: 951-955.
29. Michel G, Gluckman E, Esperou-Bordeau H, Reiffers J, OPico J, Bordigoni P et al. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: Impact of conditioning regimen without total-body irradiation - a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 1994; 12 1217-1222.
30. Gassas A, Ishaqi M, Afzal S, Finkelstein-Shecter T, Dupuis A, Doyle J. A comparison of outcomes of children with acute myelogenous leukemia in either first or second complete remission (CR1 vs CR2) following allogeneic hematopoietic stem cell transplantation at a single transplant center. Bone Marrow Transplant 2008; 41: 941-945.
31. Shenoy S, Smith F. Hematopoietic stem cell transplantation for childhood malignancies of myeloid origin. Bone Marrow Transplant 2008; 41 141-148.
32. Sedlacek P, Formankova R, Mejstrikova E, Keslova P, Hubacek P, Dobrovolna M et al. Allogeneic stem cell transplantation in children with leukemia using human leukocyte antigen-mismatched unrelated donors. Pediatr Transplant 2008; 12: 24-31.